Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

Licensing


Embracing Partnerships

Welcome! At Merck, we are strongly committed to partnership success. We recognize that the greatest achievements are not reached alone. They are the result of teamwork

We are serious about our commitment to strategic alliances. Our goal is to work together with our partners to remain in the forefront of turning scientific breakthroughs into medicines that make a difference.

We have established a clear path to partnering, and we invite you to explore the combining of your
strengths with ours, and the successes
we may share.


Richard T. Clark, Chief Executive Officer and President
“At Merck, partnering is an essential component of our strategy to discover and develop novel medicines that meet major unmet medical needs. We place a premium on our ability to identify the best external opportunities, and to offer the unique talents of both Merck Research Laboratories and of our Sales and Marketing organizations to bring your ideas to the patients who need them.”

Richard T. Clark
Chairman, President and Chief Executive Officer


Mervyn Turner, Ph.D. Chief Strategy Officer and Senior Vice President of Worldwide Licensing and External Research“Most of the world’s biomedical research takes place outside of our laboratories, so we charge our scientists with building a 'virtual lab' – the blending of the best scientific programs from internal research and external collaborations. We want to help you take your great science and turn it into great medicine. We want to help you make a difference in the lives of patients all around the world. That’s why we are all in this together.”

Mervyn Turner, PhD
Chief Strategy Officer, Merck & Co., Inc., and
Senior Vice President, Worldwide Licensing and External Research
Merck Research Laboratories


Barbara Yanni, Chief Licensing Officer“Flexibility and creativity are critical components of our negotiation process. We’re interested in listening to you, to find the best way to bring your discovery through development to market.”

Barbara Yanni
Vice President and Chief Licensing Officer







This Web site contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. more>>

* These files are presented in PDF format.  This software is available at no charge through the Adobe Web site.  Get Adobe Reader
 

Contact Us | Site Map | Policy | Terms of Use | Copyright 1995-2009 Merck & Co., Inc.